Mannosyl-1 phosphates, preparation method and therapeutic...

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 11/04 (2006.01) A61K 31/7024 (2006.01)

Patent

CA 2642843

The invention concerns .alpha.-D-mannopyranosyl-1 phosphate derivatives of formulae (I), (II) and (II) as medicines, wherein each R11 to R14, R21 to R24, R31 to R34 is H or a OH-protecting group, and R and R' are such as defined in the description, useful as cellular sources of Man-1 P, against the CDG-I syndrome and in particular the CDG-Ia syndrome. The invention also concerns said derivatives as industrial products as well as their preparation method.

La présente invention concerne en tant que médicaments les dérivés de .alpha.-D-mannopyranosyl-1 phosphate de formules (I), (II) et (III) (où chaque groupe R11 à R14, R21 à R24, R31 à R34 est H ou un groupe OH- protecteur, et R et R' sont définis comme indiqué dans la description), utilisables comme sources cellulaires de Man-1 P, vis-à-vis du syndrome CDG-I et en particulier du syndrome CDG-Ia. L'invention concerne également ces dérivés en tant que produits industriels ainsi que leur procédé de préparation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mannosyl-1 phosphates, preparation method and therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mannosyl-1 phosphates, preparation method and therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mannosyl-1 phosphates, preparation method and therapeutic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1951845

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.